Loading the player...
Closed Captioning / Subtitles Available
Information
Psychedelic-Assisted Therapy for Addiction and Co-Occurring Disorders: Innovative Treatments for Effective Recovery
Copyright :
The world of psychedelics is captivating minds and sparking curiosity like never before. As dedicated therapists, it's not just an option but an imperative to stay informed about the clinical realm of these substances and the transformative potential they hold. The key lies in understanding the crucial distinction between recreational consumption and their integration within an intentional therapeutic framework and a solid therapeutic alliance.
Amidst the burgeoning interest, it's essential to discern the reality from the hype. While psychedelics might seem like a shortcut, the truth is more intricate. These compounds aren't a magical cure-all or an escape from the work of authentic healing and enduring recovery. It's paramount to explore their potential within a therapeutic context and grasp the nuanced conversations they entail.
This presentation is your gateway to uncovering the potential of these therapies as adjunctive tools for treating addiction and other co-occurring disorders. It will highlight clients who may be appropriate for this treatment and explore the potential risks and opportunities of using psychedelics for therapeutic purposes. Become the beacon of clarity as you demystify misconceptions and lay the foundation for responsible, evidence-based practice.
Chantelle Thomas, PhD
Dr. Chantelle Thomas is a clinical psychologist and executive clinical director of Windrose Recovery – a multi-level residential addiction treatment program offering detoxification, intensive outpatient programming, and integrated ketamine-assisted psychotherapy. Dr. Thomas has been directly involved in clinical research trials at the University of Wisconsin School of Medicine and Public Health investigating the clinical use of psychedelics for over nine years. Current trials include the study of psilocybin for addiction and depression and MDMA for PTSD. She currently serves as a supervisor and trainer on the MAPS sponsored clinical trials of MDMA-assisted psychotherapy for PTSD for US and European clinical trials and Expanded Access Program. Dr. Thomas completed a postdoctoral fellowship in health psychology at the University of Wisconsin School of Medicine and Public Health and is a certified biofeedback practitioner. Her areas of specialization include chronic pain, trauma-related disorders, substance use disorders, and psychedelic integration.
Speaker Disclosures:
Financial: Dr. Chantelle Thomas has employment relationships with Windrose Recovery & Integrata, Integrative Psychiatry Institute, University of Wisconsin, The Manor, and Dane County. She is a consultant with Usona Institute, MAP PBC and Mindmed. Dr. Thomas is a trainer with Fluence Training. She is a therapist who is working on a clinical trial sponsored by Revive Therapeutics. Dr. Thomas receives a speaking honorarium from Psychotherapy Networker and PESI, Inc. All relevant financial relationships with ineligible organizations have been mitigated.
Non-financial: Dr. Chantelle Thomas is an author with Psychotherapy Networker.
